Jennifer Tenhover, NP
Nurse Practitioner · Durham, NCNPI 1659422608
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,541 of the $41,510 with a category attached, or 63.9%. Amgen accounts for 65.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $19,153, more than ten times the $238 reported in 2021. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $477.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$27K
- G1 Therapeutics, Inc.$8K
- Pharmacosmos Therapeutics Inc.$4K
- GSK$640
- Daiichi Sankyo Inc.$372
- Galvanize Therapeutics, Inc$348
- plus $1K from 7 others
What the payments were for
- Consulting fees$6402%
- Speaking & faculty fees$26,54164%
- Travel & lodging$10,92426%
- Food & beverage$3,4058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 49 | $27,215 |
| G1 Therapeutics, Inc. | 15 | $8,208 |
| Pharmacosmos Therapeutics Inc. | 6 | $3,643 |
| GSK | 1 | $640 |
| Daiichi Sankyo Inc. | 4 | $372 |
| Galvanize Therapeutics, Inc | 2 | $348 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $244 |
| AstraZeneca | 2 | $238 |
| Jazz Pharmaceuticals Inc. | 2 | $226 |
| Sanofi | 1 | $119 |
| Genentech USA, Inc. | 1 | $111 |
| Merck | 1 | $86 |
| Regeneron Healthcare Solutions, Inc. | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,510 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 38 | $2,063 |
| Potassium Chloride | 32 | $1,614 |
| Levothyroxine Sodium | 140 | $1,202 |
| Oxycodone Hcl | 24 | $596 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $494 |
| Dexamethasone | 24 | $366 |
| Prochlorperazine Maleate | 21 | $265 |
| Lidocaine Hcl ViscousLidocaine Hcl | 25 | $253 |
| Mirtazapine | 23 | $239 |
| Bupropion XlBupropion Hcl | 12 | $148 |
| Ondansetron Hcl | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Durham
- Bridget ArchambaultDurham$57K
- Cynthia SimonsonDurham$39K
- Christine AndersonDurham$20K
- Kristi WigginsDurham$18K
- Anderson GarrettDurham$15K
- Sarah WoodDurham$14K
- Kathryn KreiderDurham$13K
- Maryellen KellyDurham$12K
- Jamie HollowellDurham$11K
- Sandrivette JohnsonRaleigh$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.